Dermatitis, Atopic: all 1,443 studies

Page 8 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.

• An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in ChinaCompletedNCT06421740
• Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in SpainActive, not recruitingNCT06415175
• Use of a Mobile Health App in Managing Pediatric Atopic DermatitisCompletedNCT06412094Not applicable
• A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic DermatitisActive, not recruitingNCT06407934Phase 3
• A Study Evaluating APG777 in Atopic DermatitisActive, not recruitingNCT06395948Phase 2
• A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Moderate to Severe Atopic DermatitisWithdrawnNCT06390722Phase 3
• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to DupilumabActive, not recruitingNCT06389136Phase 3
• Study of TDM-180935 in Atopic Dermatitis PatientsCompletedNCT06363461Phase 2
• Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in ChildrenCompletedNCT06361992Phase 3
• Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)CompletedNCT06353087
• Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe ADCompletedNCT06345404Phase 1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological DiseasesCompletedNCT06342713Phase 1
• Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic DermatitisCompletedNCT06324812Phase 1/2
• Prenatal Exposure to Emerging Contaminants and Children's Atopic DermatitisActive, not recruitingNCT06316609
• Topical YR001 Ointment in Adult With Mild to Moderate Atopic DermatitisCompletedNCT06309355Phase 2
• Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid TherapyCompletedNCT06283550Phase 2
• Study of CM310 Injection in Adolescent Subjects With Atopic DermatisCompletedNCT06277765Phase 3
• A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.CompletedNCT06277245Phase 3
• An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and PsoriasisCompletedNCT06275659Not applicable
• Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis SymptomsCompletedNCT06268847Not applicable
• A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic DermatitisCompletedNCT06248814Phase 1
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK InhibitorActive, not recruitingNCT06241118Phase 3
• A Pilot Study of Efficacy and Safety of SIM05 in Adults With Atopic EczemaActive, not recruitingNCT06230991Not applicable
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical CorticosteroidsCompletedNCT06224348Phase 3
• A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic DermatitisCompletedNCT06224192Phase 3
• A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese ParticipantsCompletedNCT06214481Phase 1
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)CompletedNCT06181435Phase 3
• A Study of TAVO101 in Atopic Dermatitis PatientsActive, not recruitingNCT06176040Phase 2
• Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic DermatitisCompletedNCT06173284Phase 3
• A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving DupilumabActive, not recruitingNCT06169527
• Study of CM310 in Children Subjects With Moderate-to-severe Atopic DermatisCompletedNCT06162507Phase 1/2
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic DermatitisCompletedNCT06130566Phase 3
• The Effect of Nature-based Exposure on the Immune System and Skin Health of Atopic Dermatitis Patients.CompletedNCT06129136Not applicable
• A Study of CM310 in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT06116565Phase 2
• Dupilumab De-escalation in Pediatric Atopic DermatitisTerminatedNCT06116526Phase 4
• Evaluation of the Efficacy of TOPIALYSE Baume Protect+ on Atopic DermatisCompletedNCT06108570Not applicable
• Evaluate the Safety, Tolerability of BAT6026Active, not recruitingNCT06094179Phase 1/2
• A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic DermatitisCompletedNCT06092762Phase 2
• A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic DermatitisCompletedNCT06085521Phase 2
• A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult VolunteersCompletedNCT06082323Phase 1
• Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic DermatitisTerminatedNCT06058156Phase 2
• A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic DermatitisCompletedNCT06058000Phase 2
• A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic DermatitisWithdrawnNCT06055374Phase 1
• Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic DermatitisActive, not recruitingNCT06039241
• Probiotics and Breastmilk Decrease Risk of Atopic Dermatitis in Premature InfantsCompletedNCT06035835
• A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic DermatitisCompletedNCT06035354Phase 1/2
• Patient with Atopic Dermatitis' Needs for Self-management Support - Flexible Patient Centred ConsultationsActive, not recruitingNCT06032403Not applicable
• Phase 2 Trial of HY209gel in Atopic Dermatitis PatientsCompletedNCT06024499Phase 2
• A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With PlaceboCompletedNCT06015308Phase 2
• Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic DermatitisCompletedNCT06009094Phase 1
• Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic DermatitisTerminatedNCT06005792Phase 1
• Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic DermatitisCompletedNCT05997927Phase 2
• A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic DermatitisActive, not recruitingNCT05995964Phase 2
• The Role of Human Milk Oligosaccharides and Microbiomes on Infantile Colic and Atopic Dermatitis in Term InfantsActive, not recruitingNCT05992493
• Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA)CompletedNCT05989932
• A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic DermatitisActive, not recruitingNCT05983068Phase 4
• A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic DermatitisStatus unknownNCT05970432Phase 2
• Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT05969730Not applicable
• Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic DermatitisCompletedNCT05959083
• NiPPeR Randomised Trial - Child Follow Up StudyCompletedNCT05934422Not applicable
• Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult SubjectsCompletedNCT05932888Phase 1
• Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic DermatitisCompletedNCT05916365Phase 3
• Nutrients-fortified Egg Consumption on Eczema Condition in Individuals With EczemaActive, not recruitingNCT05913791Not applicable
• A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe ADActive, not recruitingNCT05905133Phase 2
• Insulin Resistance in Atopic Dermatitis PatientsCompletedNCT05904509
• Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic DermatitisCompletedNCT05891119Early Phase 1
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)TerminatedNCT05882877Phase 3
• Dynamic Blood Inflammatory Profile in Atopic Dermatitis Patients (ADAMUNE)Active, not recruitingNCT05868824Not applicable
• Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)TerminatedNCT05859724Phase 1
• Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic DermatitisCompletedNCT05844618Phase 4
• A First-in-Human Study of QY211 Gel in Adult SubjectsStatus unknownNCT05843422Phase 1
• Use of Complementary and Alternative Medicine in Children and Adults With Atopic DermatitisCompletedNCT05833880
• Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 5 Days of Use on Subjects With Atopic DermatitisCompletedNCT05807113Not applicable
• An Evaluation of 9MW1911 Injection in Healthy SubjectsCompletedNCT05803902Phase 1
• Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic EczemaStatus unknownNCT05790083Not applicable
• Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 4 Weeks of Use on Subjects With Atopic DermatitisCompletedNCT05786976Not applicable
• CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTSCompletedNCT05783453
• A Study of Hemay005 in Adult With Atopic DermatitisCompletedNCT05769946Phase 2
• Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic DermatitisActive, not recruitingNCT05769777Phase 2
• Effect of Lipikar Baume AP+M on Quality of Life and Pain of Adults With Dryness or Severe XerosisCompletedNCT05765461
• The Efficacy of NTU 101 Lactic Acid Bacteria Powder in the Adjuvant Improvement of Atopic Dermatitis Clinical TrialStatus unknownNCT05719649Not applicable
• A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)CompletedNCT05717920Phase 2
• Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT05715320Phase 2
• The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema)Active, not recruitingNCT05704205Not applicable
• Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment ResponseStatus unknownNCT05692843Phase 4
• Ophthalmological Adverse Events of Tralokinumab in ADCompletedNCT05682976
• Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in ChinaCompletedNCT05680298Phase 4
• The Study of CM326 in Adult Subjects With Atopic DermatitisStatus unknownNCT05671445Phase 2
• The Study of CM326 in Moderate-to-severe Atopic DermatitisStatus unknownNCT05671432Phase 2
• An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real WorldActive, not recruitingNCT05669794
• To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With ADCompletedNCT05667623Phase 3
• Development of Peanut, Sesame, and Tree Nut Allergy in Polish Children at High Risk of Food AllergyStatus unknownNCT05662800
• To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with ADCompletedNCT05650320Phase 3
• Impact of the Daily Use of Emollient on Corticosteroids Consumption in Patients With Atopic DermatitisCompletedNCT05644691
• Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic DermatitisCompletedNCT05642208Phase 4
• Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT05641558Phase 1/2
• Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From ADTerminatedNCT05639738Not applicable
• Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in ChinaCompletedNCT05624112Phase 4
• CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic DermatitisWithdrawnNCT05614817Phase 3
• Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in ChildrenCompletedNCT05613062Phase 1/2

← Dermatitis, Atopic overview